188 related articles for article (PubMed ID: 31428519)
1. Development and validation of an interferon signature predicting prognosis and treatment response for glioblastoma.
Zhu C; Zou C; Guan G; Guo Q; Yan Z; Liu T; Shen S; Xu X; Chen C; Lin Z; Cheng W; Wu A
Oncoimmunology; 2019; 8(9):e1621677. PubMed ID: 31428519
[No Abstract] [Full Text] [Related]
2. A novel defined risk signature of interferon response genes predicts the prognosis and correlates with immune infiltration in glioblastoma.
Xiao Y; Wang Z; Zhao M; Ji W; Xiang C; Li T; Wang R; Yang K; Qian C; Tang X; Xiao H; Zou Y; Liu H
Math Biosci Eng; 2022 Jun; 19(9):9481-9504. PubMed ID: 35942769
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Hypoxia Signature to Evaluate the Tumor Immune Microenvironment and Predict Prognosis in Glioma Groups.
Lin W; Wu S; Chen X; Ye Y; Weng Y; Pan Y; Chen Z; Chen L; Qiu X; Qiu S
Front Oncol; 2020; 10():796. PubMed ID: 32500034
[TBL] [Abstract][Full Text] [Related]
4. A Risk Classification System With Five-Gene for Survival Prediction of Glioblastoma Patients.
Wang Y; Liu X; Guan G; Zhao W; Zhuang M
Front Neurol; 2019; 10():745. PubMed ID: 31379707
[No Abstract] [Full Text] [Related]
5. Identification of potential biomarkers related to glioma survival by gene expression profile analysis.
Hsu JB; Chang TH; Lee GA; Lee TY; Chen CY
BMC Med Genomics; 2019 Mar; 11(Suppl 7):34. PubMed ID: 30894197
[TBL] [Abstract][Full Text] [Related]
6. Bioinformatic profiling identifies an immune-related risk signature for glioblastoma.
Cheng W; Ren X; Zhang C; Cai J; Liu Y; Han S; Wu A
Neurology; 2016 Jun; 86(24):2226-34. PubMed ID: 27225222
[TBL] [Abstract][Full Text] [Related]
7. Development and Validation of an IDH1-Associated Immune Prognostic Signature for Diffuse Lower-Grade Glioma.
Deng X; Lin D; Chen B; Zhang X; Xu X; Yang Z; Shen X; Yang L; Lu X; Sheng H; Yin B; Zhang N; Lin J
Front Oncol; 2019; 9():1310. PubMed ID: 31824866
[TBL] [Abstract][Full Text] [Related]
8. IFI30 Is a Novel Immune-Related Target with Predicting Value of Prognosis and Treatment Response in Glioblastoma.
Zhu C; Chen X; Guan G; Zou C; Guo Q; Cheng P; Cheng W; Wu A
Onco Targets Ther; 2020; 13():1129-1143. PubMed ID: 32103982
[TBL] [Abstract][Full Text] [Related]
9. Integrative Analysis of DNA Methylation and Transcriptome Identifies a Predictive Epigenetic Signature Associated With Immune Infiltration in Gliomas.
Zhang J; Yin J; Luo L; Huang D; Zhai D; Wang G; Xu N; Yang M; Song Y; Zheng G; Zhang Q
Front Cell Dev Biol; 2021; 9():670854. PubMed ID: 34136486
[TBL] [Abstract][Full Text] [Related]
10. Transcriptomic Profiling Identifies a DNA Repair-Related Signature as a Novel Prognostic Marker in Lower Grade Gliomas.
Zeng F; Liu X; Wang K; Zhao Z; Li G
Cancer Epidemiol Biomarkers Prev; 2019 Dec; 28(12):2079-2086. PubMed ID: 31533943
[TBL] [Abstract][Full Text] [Related]
11. A four-protein expression prognostic signature predicts clinical outcome of lower-grade glioma.
Patil V; Mahalingam K
Gene; 2018 Dec; 679():57-64. PubMed ID: 30077762
[TBL] [Abstract][Full Text] [Related]
12. A five-miRNA signature with prognostic and predictive value for MGMT promoter-methylated glioblastoma patients.
Cheng W; Ren X; Cai J; Zhang C; Li M; Wang K; Liu Y; Han S; Wu A
Oncotarget; 2015 Oct; 6(30):29285-95. PubMed ID: 26320189
[TBL] [Abstract][Full Text] [Related]
13. Identification of a Five-Pseudogene Signature for Predicting Survival and Its ceRNA Network in Glioma.
Wang Y; Liu X; Guan G; Xiao Z; Zhao W; Zhuang M
Front Oncol; 2019; 9():1059. PubMed ID: 31681595
[No Abstract] [Full Text] [Related]
14. Gene Expression Profiling Stratifies IDH-Wildtype Glioblastoma With Distinct Prognoses.
Liu YQ; Wu F; Li JJ; Li YF; Liu X; Wang Z; Chai RC
Front Oncol; 2019; 9():1433. PubMed ID: 31921684
[No Abstract] [Full Text] [Related]
15. Development and validation of a nomogram with an autophagy-related gene signature for predicting survival in patients with glioblastoma.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Aging (Albany NY); 2019 Dec; 11(24):12246-12269. PubMed ID: 31844032
[TBL] [Abstract][Full Text] [Related]
16. Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses.
Cheng W; Ren X; Zhang C; Cai J; Han S; Wu A
Mol Neurobiol; 2017 Oct; 54(8):5996-6005. PubMed ID: 27696222
[TBL] [Abstract][Full Text] [Related]
17. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a metastasis-related Gene Signature for predicting the Overall Survival in patients with Pancreatic Ductal Adenocarcinoma.
Wu M; Li X; Liu R; Yuan H; Liu W; Liu Z
J Cancer; 2020; 11(21):6299-6318. PubMed ID: 33033514
[No Abstract] [Full Text] [Related]
19. Prognosis Analysis and Validation of m
Lin S; Xu H; Zhang A; Ni Y; Xu Y; Meng T; Wang M; Lou M
Front Oncol; 2020; 10():541401. PubMed ID: 33123464
[TBL] [Abstract][Full Text] [Related]
20. Development of a Nomogram With Alternative Splicing Signatures for Predicting the Prognosis of Glioblastoma: A Study Based on Large-Scale Sequencing Data.
Wang Z; Gao L; Guo X; Feng C; Lian W; Deng K; Xing B
Front Oncol; 2020; 10():1257. PubMed ID: 32793502
[No Abstract] [Full Text] [Related]
[Next] [New Search]